Kexing Biopharm Co., Ltd. (688136)
Market Closed
16 Oct, 06:57 AM
SSE SSE Primary ¥
20. 17
-0.23
-1.1275%
¥
3.41B Market Cap
- P/E Ratio
0.4% Div Yield
8.28M Volume
- Eps
¥ 20.4
Previous Close Want to track 688136 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Kexing Biopharm Co., Ltd. (688136) Statistics
Valuation metrics
Market Cap 3.41B
Enterprise value 5.59B
Trailing P/E (ttm) 21.53
Forward P/E -
PEG ratio 0.19
Price/Sales (ttm) 3.19
Price/Book (mrq) 2.51
Enterprise Value/Revenue 3.86
Enterprise Value/EBITDA 83.71
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 9.82M
Average volume (90 days) 7.55M
Price summary
52-Week low 17
52-Week high 41.5
Beta -
50-Day moving average 21.8
200-Day moving average 22.76
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.25
Trailing annual dividend yield 0.0108%
5-Year annual dividend yield -
Payout ratio 0.38
Dividend Date 15 Jun 2026
Ex-Dividend Date 15 Jun 2026
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.15%
Operating margin 0.17%
Operational effectiveness
Return on assets 0.06%
Return on equity 0.12%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 7.29
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 1.07
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.07
Total debt (mrq) -
Total Debt/Equity (mrq) 0.82
Current ratio (mrq) 1.34%
Book value per share (mrq) 9.26
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
